These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33891960)

  • 21. Surface-Modification of RIPL Peptide-Conjugated Liposomes to Achieve Steric Stabilization and pH Sensitivity.
    Kwon YH; Shin TH; Jang MH; Yoon HY; Kang MH; Kang MJ; Choi YW
    J Nanosci Nanotechnol; 2017 Feb; 17(2):1008-17. PubMed ID: 29671978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel liposome surface modification agent that prolongs blood circulation and retains surface ligand reactivity.
    Ishihara A; Yamauchi M; Tsuchiya T; Mimura Y; Tomoda Y; Katagiri A; Kamiya M; Nemoto H; Suzawa T; Yamasaki M
    J Biomater Sci Polym Ed; 2012; 23(16):2055-68. PubMed ID: 22054261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted Magnetic Liposomes Loaded with Doxorubicin.
    Pradhan P; Banerjee R; Bahadur D; Koch C; Mykhaylyk O; Plank C
    Methods Mol Biol; 2017; 1522():257-272. PubMed ID: 27837546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein adsorption to polyethylene glycol modified liposomes from fibrinogen solution and from plasma.
    Price ME; Cornelius RM; Brash JL
    Biochim Biophys Acta; 2001 Jun; 1512(2):191-205. PubMed ID: 11406096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and properties of branched oligoglycerol modifiers for stabilization of liposomes.
    Ishihara A; Yamauchi M; Kusano H; Mimura Y; Nakakura M; Kamiya M; Katagiri A; Kawano M; Nemoto H; Suzawa T; Yamasaki M
    Int J Pharm; 2010 May; 391(1-2):237-43. PubMed ID: 20298767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surface Ligand Valency and Immunoliposome Binding: when More Is Not Always Better.
    Li H; Di J; Peng B; Xu Y; Zhang N
    Pharm Res; 2021 Sep; 38(9):1593-1600. PubMed ID: 34463936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromatographic retention of drug molecules on immobilised liposomes prepared from egg phospholipids and from chemically pure phospholipids.
    Osterberg T; Svensson M; Lundahl P
    Eur J Pharm Sci; 2001 Feb; 12(4):427-39. PubMed ID: 11231109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineering liposomal nanoparticles for targeted gene therapy.
    Zylberberg C; Gaskill K; Pasley S; Matosevic S
    Gene Ther; 2017 Aug; 24(8):441-452. PubMed ID: 28504657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New detachable poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natural phospholipid, diacyl phosphatidylethanolamine.
    Zalipsky S; Qazen M; Walker JA; Mullah N; Quinn YP; Huang SK
    Bioconjug Chem; 1999; 10(5):703-7. PubMed ID: 10502334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liposome functionalization with copper-free "click chemistry".
    Oude Blenke E; Klaasse G; Merten H; Plückthun A; Mastrobattista E; Martin NI
    J Control Release; 2015 Mar; 202():14-20. PubMed ID: 25626085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of surface modified liposomes on the aggregation of platelets and tumor cells.
    Keil C; Zeisig R; Fichtner I
    Thromb Haemost; 2005 Aug; 94(2):404-11. PubMed ID: 16113832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triggered liposomal release through a synthetic phosphatidylcholine analogue bearing a photocleavable moiety embedded within the sn-2 acyl chain.
    Bayer AM; Alam S; Mattern-Schain SI; Best MD
    Chemistry; 2014 Mar; 20(12):3350-7. PubMed ID: 24615893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups.
    Torchilin VP; Levchenko TS; Lukyanov AN; Khaw BA; Klibanov AL; Rammohan R; Samokhin GP; Whiteman KR
    Biochim Biophys Acta; 2001 Apr; 1511(2):397-411. PubMed ID: 11286983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine.
    Webb MS; Saxon D; Wong FM; Lim HJ; Wang Z; Bally MB; Choi LS; Cullis PR; Mayer LD
    Biochim Biophys Acta; 1998 Jul; 1372(2):272-82. PubMed ID: 9675310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A single-step method of liposome preparation.
    Zawada Z
    Cell Mol Biol Lett; 2004; 9(4A):603-15. PubMed ID: 15647784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding liposomal properties to aid their clinical usage.
    Harwood JL
    Trends Biochem Sci; 1992 Jun; 17(6):203-4. PubMed ID: 1502719
    [No Abstract]   [Full Text] [Related]  

  • 37. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
    Al-Jamal WT; Kostarelos K
    Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery.
    Hong K; Zheng W; Baker A; Papahadjopoulos D
    FEBS Lett; 1997 Jan; 400(2):233-7. PubMed ID: 9001404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of polyethylene glycol-lipid derivatives on the stability of grafted liposomes].
    Xu Y; Shi L; Deng YH
    Yao Xue Xue Bao; 2011 Oct; 46(10):1178-86. PubMed ID: 22242447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poly(ethylene glycol)-modified phospholipids prevent aggregation during covalent conjugation of proteins to liposomes.
    Harasym TO; Tardi P; Longman SA; Ansell SM; Bally MB; Cullis PR; Choi LS
    Bioconjug Chem; 1995; 6(2):187-94. PubMed ID: 7599262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.